Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer | |
Yang, Mei1; Fan, Yanhui2; Wu, Zhi-Yong3; Feng, Zhendong2; Zhang, Qiangzu2; Han, Shunhua2; Zhang, Zhonghai5; Li, Xu5; Xue, Yiqing2; Li, Xiaoling1 | |
刊名 | CANCER RESEARCH |
2021-02-01 | |
卷号 | 81期号:4页码:1 |
ISSN号 | 0008-5472 |
WOS研究方向 | Oncology |
语种 | 英语 |
出版者 | AMER ASSOC CANCER RESEARCH |
WOS记录号 | WOS:000618737701207 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.204/handle/2XEOYT63/16896] |
专题 | 中国科学院计算技术研究所 |
作者单位 | 1.Guangdong Prov Peoples Hosp, Guangzhou, Guangdong, Peoples R China 2.Phil Rivers Technol, Beijing, Peoples R China 3.Sun Yat Sen Univ, Shantou Affiliated Hosp, Shantou, Peoples R China 4.Tsinghua Univ, Sch Med, Beijing, Peoples R China 5.Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China 6.Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China |
推荐引用方式 GB/T 7714 | Yang, Mei,Fan, Yanhui,Wu, Zhi-Yong,et al. Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer[J]. CANCER RESEARCH,2021,81(4):1. |
APA | Yang, Mei.,Fan, Yanhui.,Wu, Zhi-Yong.,Feng, Zhendong.,Zhang, Qiangzu.,...&Wang, Kun.(2021).Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer.CANCER RESEARCH,81(4),1. |
MLA | Yang, Mei,et al."Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer".CANCER RESEARCH 81.4(2021):1. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论